Impact of New Technologies on Pharmacogenomics

Background: Genomic basis of drug response is the main objective of Pharmacogenomic studies. The classical paradigm of clinical treatment focused in the disease is becoming a new approach, the Personalized Medicine (PM) based on the individual patient. One important challenge of PM application is the availability of adequate and validated genetic information. Keywords: Nanopores, personalized medicine, pharmacogenetics, pharmacogenomics, sequencing, single cell sequencing.